Funding
Funding not disclosed
Founders
Product
Problem
A significant portion of the adult population faces the risk of developing chronic non-communicable diseases, with a large percentage of cancer diagnoses occurring in advanced stages, leading to compromised treatment effectiveness and reduced quality of life. Traditional methods often fail to provide timely and personalized preventative care, resulting in delayed diagnoses and increased healthcare costs.
Solution
WeConecta is a digital health platform that leverages artificial intelligence to predict risk and facilitate early diagnosis of non-communicable diseases. The platform employs a virtual assistant chatbot on WhatsApp to collect real-time health behavior data and map family history, identifying individuals at risk. WeConecta then connects at-risk individuals with personalized care pathways, promoting prevention and early diagnosis through a fully digital experience. The platform provides remote patient monitoring, personalized medicine based on health behavior, and facilitates easy scheduling of consultations via WhatsApp.
Target Audience
WeConecta primarily targets healthcare providers, hospitals, and health insurance companies seeking to improve early disease detection, personalize patient care, and optimize resource allocation in primary care.
Features
- AI-powered risk prediction algorithms for non-communicable diseases, including various types of cancer, cardiovascular diseases, and mental health conditions
- Remote health behavior data collection and real-time monitoring
- Virtual assistant (chatbot) on WhatsApp for patient engagement and data collection
- Personalized health reports with identified risk factors
- Connection to specific care pathways based on individual characteristics
- Dashboards for real-time health data monitoring and risk identification
- White-label platform option for enterprise clients
- Genetic risk assessment for breast cancer